js global life Limited (the "Company")'s summarized interim financial information for the six months ended June 30, 2024, shows that the total revenue from continuing operations of the Company was 743.0 million US dollars, an increase of 29.5% year-on-year. The gross margin was 245.8 million US dollars, an increase of 15.2% year-on-year. The gross margin rate was 33.1%, a decrease of 4.1 percentage points compared to the same period last year's 37.2%. The profit from continuing operations during the reporting period decreased by 35.9% year-on-year to approximately 29.6 million US dollars. The profit attributable to the owners of the parent company decreased by approximately 37.0% year-on-year to approximately 21.8 million US dollars. EBITDA for the reporting period decreased by 43.0% year-on-year to...Show More

js global life Limited (the "Company")'s summarized interim financial information for the six months ended June 30, 2024, shows that the total revenue from continuing operations of the Company was 743.0 million US dollars, an increase of 29.5% year-on-year. The gross margin was 245.8 million US dollars, an increase of 15.2% year-on-year. The gross margin rate was 33.1%, a decrease of 4.1 percentage points compared to the same period last year's 37.2%. The profit from continuing operations during the reporting period decreased by 35.9% year-on-year to approximately 29.6 million US dollars. The profit attributable to the owners of the parent company decreased by approximately 37.0% year-on-year to approximately 21.8 million US dollars. EBITDA for the reporting period decreased by 43.0% year-on-year to approximately 41.7 million US dollars, and the adjusted EBITDA for the reporting period decreased by 64.4% year-on-year to approximately 28.1 million US dollars. The adjusted net profit for the reporting period decreased by 69.2% year-on-year to approximately 16.0 million US dollars. During the reporting period, the group acquired 68.4517% equity interest of Shenzhen Cicada asia vets Limited. The purchase consideration for the acquisition was paid in cash before the acquisition date, with 2,868,000 US dollars paid, and 14,674,000 US dollars paid on the acquisition date. Since the acquisition date, Shenzhen Cicada asia vets Limited has contributed revenue of approximately 5,617,000 US dollars and a net loss of 1,553,000 US dollars to the group. If the consolidation is carried out at the beginning of the period, the group's revenue and profit from continuing operations for the period would be 747,438,000 US dollars and 27,065,000 US dollars respectively.